ConductScience.org, home

Comparison · NCT02444988-f77fdc58

0.9% Sodium Chloride (Saline) vs Balanced Crystalloid: 30-day In-hospital Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. 0.9% Sodium Chloride (Saline) vs Balanced Crystalloid: 30-day In-hospital Mortality. Trial comparisons, record NCT02444988-f77fdc58. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02444988-f77fdc58

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1760.1620.191wilson
Risk in group 20.1530.140.167wilson
Risk difference, group 1 minus group 20.02370.003840.0435newcombe hybrid score
Risk ratio, group 1 over group 21.151.021.3log
Odds ratio, group 1 over group 21.191.031.37log
Number needed to treat, for one more participant with the outcome on 0.9% Sodium Chloride (Saline) than on Balanced Crystalloid42.323260from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 10.9% Sodium Chloride (Saline)
Patients in an ICU block randomized to saline will receive 0.9% sodium chloride whenever isotonic intravenous fluid administration is ordered by the treating provider.~Saline: 0.9% sodium chloride will be used whenever an isotonic crystalloid is ordered
4672,646OG000
Group 2Balanced Crystalloid
Patients in an ICU block randomized to balanced crystalloid will receive Plasma-Lyte A or Lactated Ringer's whenever isotonic intravenous crystalloid administration is ordered by the treating provider.~Balanced crystalloid: Lactated Ringers or Plasma-Lyte A will be used whenever an isotonic crystalloid is ordered
4182,735OG001

Outcome

Type
SECONDARY
Title
30-day In-hospital Mortality
Description
Death before hospital discharge, censored at 30 days after enrollment
Time frame
30 days after enrollment censored at hospital discharge
Population

Source ClinicalTrials.gov

Trial

Title
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
NCT number
NCT02444988
Phases
NA
Conditions
Critical Illness, Acute Kidney Injury
Interventions
0.9% Saline, Physiologically-balanced isotonic crystalloid
Lead sponsor
Vanderbilt University
Results first posted
2019-11-25

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02444988-f77fdc58